Interpace Biosciences, Inc.
(Other OTC/NBB : IDXG)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Services » Servicestothe Health Industry
symbolcompany%chnglast%shortavg$volume
LHLaboratory Corp. of America Holdings -0.58%276.192.4%$240.05m
IQVIQVIA Holdings, Inc. -1.84%247.440.0%$195.61m
DGXQuest Diagnostics, Inc. -1.89%142.274.7%$159.37m
AMEHApollo Medical Holdings, Inc. -1.13%60.350.0%$25.79m
NOTVInotiv, Inc. 2.18%32.860.0%$6.64m
NRCNational Research Corp. -1.16%38.210.0%$1.58m
PLXProtalix Biotherapeutics, Inc. -3.96%0.8518.5%$0.44m
QIPTQuipt Home Medical Corp. -2.08%5.650.0%$0.27m
PMDPsychemedics Corp. 0.70%7.170.7%$0.14m

Company Profile

Interpace Biosciences, Inc. operates as an bioinformatics company, which engages in the development and commercialization of molecular diagnostic test and pathology services. It offers PancraGEN, a pancreatic cyst and pancreaticobiliary solid lesion molecular test that can aid in pancreatic cyst diagnosis and pancreatic cancer risk assessment; ThyGenX and PathFinderTG which assesses thyroid nodules for risk of malignancy; and ThyraMIR, which assesses thyroid nodules for risk of malignancy utilizing a proprietary gene expression assay. The company was founded by John P. Dugan in 1987 and is headquartered in Parsippany, NJ.